Novel Hepatitis B Drug Hints at Long-Term 'Functional Cure' for Some in Early Trial

(MedPage Today) -- WASHINGTON -- Investigational antisense RNA-based therapy bepirovirsen sustained clearance of both hepatitis B virus (HBV) DNA and surface antigen (HBsAg) for a modest proportion of patients out to 6 months after injections...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news